The Globe and Mail reports in its Friday, Nov. 14, edition that Raymond James analyst Stephen Boland continues to rate Canaccord Genuity Group "strong buy." The Globe's David Leeder writes that Mr. Boland bumped his share target ahead by a loonie to $14. Analysts on average target the shares at $13.38. Mr. Boland says in a note: "With the improvement in capital markets results, expanding wealth margins, and a possible resolution to the ongoing U.S. regulatory matter, we expect the shares to react positively. We'd also note that a near-term a potential monetization/sale of U.K. wealth is possibly approaching, with the media recently reporting that the division could sell for in excess of 1 billion pounds. With this in mind, we believe a sale could provide further upside despite recent strength in the shares following the initial report." The Globe reported on Aug. 9, 2023, that Mr. Boland had boosted Canaccord Genuity to "strong buy" from "outperform." He said he saw "limited downside risk." The shares could then be had for $8.19. The Globe reported on Aug. 13, 2025, that TD Cowen analyst Graham Ryding had boosted his recommendation for Canaccord Genuity to "buy" from "hold." The shares could then be had for $10.32.